Business Standard

Covid-19: Phase-3 trial of COVAXIN to begin in Lucknow, Gorakhpur from Oct

The Uttar Pradesh government announced that phase-3 trial of the coronavirus vaccine 'COVAXIN' will start in Lucknow and Gorakhpur from October

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma

Representative image

ANI General News

The Uttar Pradesh government on Thursday announced that phase-3 trial of the coronavirus vaccine 'COVAXIN' will start in Lucknow and Gorakhpur from October.

"The phase-3 trial of COVAXIN being developed by Bharat Biotech will start in Lucknow and Gorakhpur from October," said Uttar Pradesh Principal Health Secretary Amit Mohan Prasad here in a press conference.

Click here to connect with us on WhatsApp

The Indian Council for Medical Research (ICMR) is collaborating with Bharat Biotech for the development of the COVAXIN.

Meanwhile, Congress leader Deepak Singh on Thursday wrote a letter to Chief Minister Yogi Adityanath and requested to increase testing for COVID-19 in Uttar Pradesh.

 

According to the Union Health Ministry as of Thursday, there are 61,698 active cases in the state with 3,02,689 recovered people and 5,299 deaths.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 25 2020 | 7:45 AM IST

Explore News